Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions-Reference-Cited by-同舟云学术

Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions

Published:2021-07 Issue: Volume:Volume 8 Page:741-757
ISSN:2253-5969
Container-title:Journal of Hepatocellular Carcinoma
language:en
Short-container-title:JHC

Author:

Fornari Francesca^ORCID,Giovannini Catia,Piscaglia Fabio^ORCID,Gramantieri Laura

Publisher

Informa UK Limited

Subject

General Medicine

Reference96 articles.

1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.

2. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

3. Sorafenib

4. Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Novel Indole-Based Covalent Inhibitors of TEAD as Potential Antiliver Cancer Agents;Journal of Medicinal Chemistry;2024-09-13

2. Targeted degradation of NDUFS1 by agrimol B promotes mitochondrial ROS accumulation and cytotoxic autophagy arrest in hepatocellular carcinoma;Free Radical Biology and Medicine;2024-08

3. MVP enhances FGF21‐induced ferroptosis in hepatocellular carcinoma by increasing lipid peroxidation through regulation of NOX4;Clinical and Translational Science;2024-08

4. Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma;Digestive and Liver Disease;2024-08

5. Subcellular distribution and Nrf2/Keap1-interacting properties of Glutathione S-transferase P in hepatocellular carcinoma;Archives of Biochemistry and Biophysics;2024-07